AquaBounty Technologies, Inc. announced that its Board of Directors determined not to implement the previously approved reverse stock split authority granted by stockholders-at-the-June 23, 2026, Annual Meeting. The authority to effect a reverse stock split between 1-for-5 and 1-for-20 ratio will expire on July 31, 2026, without being exercised. AquaBounty Technologies, Inc. operates in the aquaculture industry and develops genetically modified salmon.

On June 25, 2026, AquaBounty Technologies, Inc. completed a private placement, issuing 109,223 shares of Series B Convertible Preferred Stock for aggregate gross proceeds of $2,250,000. The Series B Preferred Stock has a liquidation value of $20.60 per share, an 18.0% annual dividend accruing quarterly, and is convertible into common stock at an initial price of $1.03 per share. Univest Securities, LLC served as the placement agent and received a fee of 7.0% of gross proceeds. Net proceeds are intended for working capital and general corporate purposes. The company operates in the aquaculture industry and produces genetically engineered salmon.

At its Annual Meeting on June 23, 2026, AquaBounty Technologies stockholders approved an amendment to the Certificate of Incorporation granting the Board discretion to execute a reverse stock split with a ratio between 1-for-5 and 1-for-20. The Board must determine the final ratio and timing, with the split to occur no later than July 31, 2026. Stockholders also elected directors Graydon Bensler, Braeden Lichti, Rick Sterling, and Sylvia A. Wulf, ratified Deloitte & Touche LLP as the independent auditor for fiscal year 2026, and approved executive compensation on an advisory basis. The company operates in the aquaculture industry and produces genetically engineered salmon.